Mustafa Atci

16PUBLICATIONS
81CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 12, 2026
Prognostic factors and survival outcomes in older adults with extensive-stage small cell lung cancer: A multicenter retrospective cohort study.

|Apr 27, 2026
Perioperative FLOT versus Definitive 50.4 Gy Chemoradiotherapy in Siewert II Esophagogastric Junction Adenocarcinoma: A Multicenter Retrospective Cohort Study.

|Aug 27, 2025
Bevacizumab Efficacy and Tolerability in Patients with Metastatic Platinum-Sensitive Ovarian Cancer Beyond Progression.

Mert Erciyestepe, Şermin Dinç Sonuşen, Şaban Seçmeler

|Feb 17, 2025
Perioperative 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in gastric cancer: Pathological regression grade and its relationship to clinical outcome.

Muhammed M Atci, Saban Secmeler, Abdullah Sakin

|Aug 02, 2022
Real-life analysis of treatment approaches and the role of inflammatory markers on survival in patients with advanced biliary tract cancer.

Sabin Goktas Aydin, Burcin Cakan Demirel, Ahmet Bilici

|May 11, 2022
Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?

Özgecan Dülgar, Başak Bala Öven, Muhammed Mustafa Atcı

Pageof 3

Frequent Collaborators

6 joint publications

Abdullah Sakin

5 joint publications

Seval Ay

4 joint publications

Baran Akagunduz

3 joint publications

Saban Secmeler